Protection of Mice Against Encephalomyocarditis Virus Infection by Chemically Modified Transfer RNAs

References

1. Brammer K. W. 1963; Chemical modification of viral ribonucleic acid. II. Bromination and iodination. Biochimica et Biophysica Acta 72:217–229
   [Google Scholar]
2. Carbon J. 1971; Chemical modifications of transfer RNA. In Methods in Enzymology vol 20 pp 129–135 Edited by Moldave K., Grossman L. New York and London: Academic Press;
   [Google Scholar]
3. Chambers R. W., Aoyagi S., Furukawa Y., Zawadzka H., Bhanot O. S. 1973; Inactivation of valine acceptor activity by a C→ U missense change in the anti–codon of yeast valine transfer ribonucleic acid. Journal of Biological Chemistry 248:5549–5551
   [Google Scholar]
4. Dulbecco R., Smith J. D. 1960; The detection of terminal nucleoside residues in polyribonucleotides. Biochemica et Biophysica Acta 39:358–361
   [Google Scholar]
5. Eaton M. A. W., Hutchinson D. W. 1973; Poly(5–hydroxycytidylic acid). Biochimica et Biophysica Acta 319:281–287
   [Google Scholar]
6. Gierer A., Mundry K. W. 1958; Production of mutants of TMV by chemical alteration of its ribonucleic acid in vitro. Nature, London 182:1457
   [Google Scholar]
7. Goddard J. P., Schulman L. H. 1972; Conversion of exposed cytidine residues to uridine residues in Escherichia coli formylmethionine transfer ribonucleic acid. Journal of Biological Chemistry 247:3864–3867
   [Google Scholar]
8. Kucan Z., Freude K. A., Kucan I., Chambers R. W. 1971; Aminoacylation of bisulphite–modified yeast tyrosine transfer RNA. Nature New Biology 232:177–179
   [Google Scholar]
9. Lindley I. J. D., Stebbing N. 1976; Aminoacylation of encephalomyocarditis virus RNA. Journal of General Virology 34:177–181
   [Google Scholar]
10. Loening U. E. 1969; The determination of the molecular weight of ribonucleic acid by polyacrylamidegel– electrophoresis. Biochemical Journal 113:131–138
    [Google Scholar]
11. Means G. E., Fraenkel-Conrat H. 1971; Effects of bromine on the template and messenger specificities of polynucleotides. Biochimica et Biophysica Acta 247:441–448
    [Google Scholar]
12. Peto R., Pike M. C. 1973; Conservatism of the approximation ∑(O-E)²/E in the logrank test for survival data or tumour incidence data. Biometrics 29:579–584
    [Google Scholar]
13. Stebbing N., Grantham C. A., Carey N. H. 1976a; Antiviral activity of single–stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction. Journal of General Virology 30:21–39
    [Google Scholar]
14. Stebbing N., Grantham C. A., Kaminski F., Lindley I. J. D. 1976b; Protection of mice against encephalomyocarditis virus infection by preparations of transfer RNA. Journal of General Virology 34:73–85
    [Google Scholar]
15. Stebbing N., Lindley I. J. D., Eaton M. A. W. 1977; The direct antiviral activity of single–stranded polyribonucleotides. I. Potentiation of activity by mixtures of polymers which do not anneal. Proceedings of the Royal Society (in the press)
    [Google Scholar]
16. Zamecnik P. C., Yu C. T. 1971; Modification of tRNA’s by bromination. In Methods in Enzymology vol 20 pp 175–178 Edited by Moldave K., Grossman L. New York & London: Academic Press;
    [Google Scholar]